STOCK TITAN

SoftBank Vision Fund entities disclose 2.3% Roivant (ROIV) ownership in 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Roivant Sciences Ltd. received an amended ownership report from SoftBank-affiliated entities. The filing shows that SB Investment Advisers (UK) Limited, SoftBank Vision Fund L.P., SVF Holdings (UK) LLP and SVF Investments (UK) Limited together beneficially own 16,413,603 common shares, representing 2.3% of Roivant’s outstanding stock.

SVF Investments (UK) Limited is the record holder of these shares, and the other SoftBank entities may be deemed to share voting and investment power through their control structure. The ownership is calculated based on 715,701,137 common shares outstanding as of February 2, 2026 and is now reported as 5% or less of the class.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



SB Investment Advisers (UK) Limited
Signature:/s/ Amanda Sanchez-Barry
Name/Title:Amanda Sanchez-Barry, General Counsel
Date:02/17/2026
SoftBank Vision Fund L.P.
Signature:By: SB Investment Advisers (UK) Limited, its Manager, /s/ Amanda Sanchez-Barry
Name/Title:Amanda Sanchez-Barry, General Counsel
Date:02/17/2026
SVF Holdings (UK) LLP
Signature:By: SoftBank Vision Fund L.P., its Managing Member, By: SB Investment Advisers (UK) Limited, /s/ Amanda Sanchez-Barry
Name/Title:Amanda Sanchez-Barry, General Counsel
Date:02/17/2026
SVF Investments (UK) Limited
Signature:By: SVF Holdings (UK) LLP, its Sole Owner, By: SoftBank Vision Fund L.P., By: SB Investment Advisers (UK) Limited, /s/ Amanda Sanchez-Barry
Name/Title:Amanda Sanchez-Barry, General Counsel
Date:02/17/2026
Exhibit Information

Exhibit 99: Joint Filing Agreement (previously filed).

FAQ

What ownership stake in Roivant Sciences (ROIV) do the SoftBank entities report?

The SoftBank-affiliated entities report beneficial ownership of 16,413,603 Roivant common shares, equal to 2.3% of the outstanding class. This stake is calculated using 715,701,137 common shares outstanding as of February 2, 2026, as disclosed by Roivant.

Which SoftBank-related entities are reporting ownership in Roivant Sciences (ROIV)?

The filing lists SB Investment Advisers (UK) Limited, SoftBank Vision Fund L.P., SVF Holdings (UK) LLP and SVF Investments (UK) Limited as reporting persons. They may be deemed to share beneficial ownership of the same 16,413,603 Roivant common shares through their control relationships.

How many Roivant (ROIV) shares are directly held and by which SoftBank entity?

The statement identifies SVF Investments (UK) Limited as the record holder of 16,413,603 Roivant common shares. Other related SoftBank entities are upstream owners or managers and may be deemed to share beneficial ownership and voting and dispositive power over these shares.

What percentage of Roivant Sciences (ROIV) does SoftBank report owning in this Schedule 13G/A?

SoftBank-affiliated reporting persons state they beneficially own 2.3% of Roivant’s common shares. This percentage is based on 715,701,137 common shares outstanding as of February 2, 2026, as referenced from Roivant’s Form 10-K, and reflects ownership of 5% or less of the class.

What voting and dispositive powers do the SoftBank entities have over Roivant (ROIV) shares?

The filing shows zero sole voting or dispositive power and 16,413,603 shares of shared voting and shared dispositive power for each reporting person. This means decisions on voting and selling these Roivant shares are shared among the SoftBank-related entities.

As of what dates are the SoftBank ownership figures in Roivant (ROIV) calculated?

Beneficial ownership reflects holdings as of December 31, 2025, while the percentage calculation uses 715,701,137 common shares outstanding as of February 2, 2026, as disclosed in Roivant’s Form 10-K filed with the SEC on February 6, 2026.
Roivant Sciences

NASDAQ:ROIV

ROIV Rankings

ROIV Latest News

ROIV Latest SEC Filings

ROIV Stock Data

19.39B
476.20M
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
LONDON